Drospirenone and estradiol: a new option for the postmenopausal woman

@article{Archer2007DrospirenoneAE,
  title={Drospirenone and estradiol: a new option for the postmenopausal woman},
  author={D. Archer},
  journal={Climacteric},
  year={2007},
  volume={10},
  pages={10 - 3}
}
The efficacy of estrogen with or without a progestogen as hormone replacement therapy (HRT) for menopausal symptoms is well-established. Recent large-scale randomized studies with combined estrogen/progestogen therapy (EPT) have raised a number of safety issues, specifically the potential risk for coronary heart disease. Subsequent analyses and other studies have indicated that HRT may be cardioprotective in younger postmenopausal women. A new continuous EPT combines natural 17β-estradiol (E2… Expand
Clinical responses to the combination of estradiol and drospirenone in symptomatic postmenopausal Thai women.
What do TSECs provide in the menopausal hormone therapy?
  • P. Llaneza, J. Calaf, +5 authors D. Lubian
  • Medicine
  • Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2018
Progestogen safety and tolerance in hormonal replacement therapy
Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women
The use of newer progestins for contraception.
Hormonal therapy with estradiol and drospirenone improves endothelium-dependent vasodilation in the coronary bed of ovariectomized spontaneously hypertensive rats
  • M. V. Borgo, E. Claudio, +8 authors G. Abreu
  • Medicine
  • Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
  • 2016
...
1
2
3
...

References

SHOWING 1-10 OF 30 REFERENCES
Added benefits of drospirenone for compliance
  • J. Foidart
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2005
...
1
2
3
...